Page last updated: 2024-09-03

3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde and tobramycin

3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde has been researched along with tobramycin in 1 studies

Compound Research Comparison

Studies
(3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde)
Trials
(3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde)
Recent Studies (post-2010)
(3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde)
Studies
(tobramycin)
Trials
(tobramycin)
Recent Studies (post-2010) (tobramycin)
30074,9026291,205

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdullah, A; DiCicco, M; Goldfinger, A; Guirand, F; Jansen, SA1

Other Studies

1 other study(ies) available for 3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde and tobramycin

ArticleYear
In vitro tobramycin elution analysis from a novel beta-tricalcium phosphate-silicate-xerogel biodegradable drug-delivery system.
    Journal of biomedical materials research. Part B, Applied biomaterials, 2004, Jul-15, Volume: 70, Issue:1

    Topics: Anti-Bacterial Agents; Benzoates; Biocompatible Materials; Bone Substitutes; Calcium Carbonate; Calcium Phosphates; Drug Delivery Systems; Gels; Humans; Hydroxyapatites; Materials Testing; Molecular Structure; Osteomyelitis; Quinolines; Reproducibility of Results; Silicates; Tobramycin

2004